Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (151-160 of 487) with videos related to

Pageof 49
Sort By:
Cell|April 4, 2020
Snapshot: Trial Types in Precision MedicineDane Dickson, Jennifer Johnson, Raymond Bergan, et al.
JAMA Network Open|November 12, 2021
Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung CancerSreeram Ramagopalan, Alind Gupta, Paul Arora, et al.
Cancers|November 27, 2024
Association of Antibody-Drug Conjugate (ADC) Target Expression and Interstitial Lung Disease (ILD) in Non-Small-Cell Lung Cancer (NSCLC): Association or Causation or Neither?Aakash Desai, Vivek Subbiah, Sinchita Roy-Chowdhuri, et al.
Abdominal Radiology (New York)|January 2, 2021
Current update on gallbladder carcinomaDhakshinamoorthy Ganeshan, Avinash Kambadakone, Paul Nikolaidis, et al.
BMC Dermatology|April 18, 2015
Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case reportJennifer Goldstein, Anisha B Patel, Jonathan L Curry, et al.
Trends in Cancer|January 20, 2024
Impact of tissue-agnostic approvals on management of primary brain tumorsManmeet S Ahluwalia, Atulya A Khosla, Ahmad Ozair, et al.
Cancer Treatment and Research Communications|September 30, 2025
Development of anti-cancer medicines in the current eraBradley J Monk, Manish R Patel, Sarper Toker, et al.
Trends in Cancer|August 15, 2021
Precision therapy for RET-altered cancers with RET inhibitorsKyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, et al.
BMC Medicine|September 15, 2021
The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapySreeram Ramagopalan, Thomas P Leahy, Joshua Ray, et al.
JCO Precision Oncology|December 1, 2023
Exceptional Responses to Selpercatinib in <i>RET</i> Fusion-Driven Metastatic Pancreatic CancerDeepak Bhamidipati, Sireesha Yedururi, Jason Huse, et al.
Pageof 49

Showing results (151-160 of 487) with videos related to

Sort By:
Pageof 49
Cell|April 4, 2020
Snapshot: Trial Types in Precision MedicineDane Dickson, Jennifer Johnson, Raymond Bergan, et al.
JAMA Network Open|November 12, 2021
Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung CancerSreeram Ramagopalan, Alind Gupta, Paul Arora, et al.
Cancers|November 27, 2024
Association of Antibody-Drug Conjugate (ADC) Target Expression and Interstitial Lung Disease (ILD) in Non-Small-Cell Lung Cancer (NSCLC): Association or Causation or Neither?Aakash Desai, Vivek Subbiah, Sinchita Roy-Chowdhuri, et al.
Abdominal Radiology (New York)|January 2, 2021
Current update on gallbladder carcinomaDhakshinamoorthy Ganeshan, Avinash Kambadakone, Paul Nikolaidis, et al.
BMC Dermatology|April 18, 2015
Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case reportJennifer Goldstein, Anisha B Patel, Jonathan L Curry, et al.
Trends in Cancer|January 20, 2024
Impact of tissue-agnostic approvals on management of primary brain tumorsManmeet S Ahluwalia, Atulya A Khosla, Ahmad Ozair, et al.
Cancer Treatment and Research Communications|September 30, 2025
Development of anti-cancer medicines in the current eraBradley J Monk, Manish R Patel, Sarper Toker, et al.
Trends in Cancer|August 15, 2021
Precision therapy for RET-altered cancers with RET inhibitorsKyaw Z Thein, Vamsidhar Velcheti, Blaine H M Mooers, et al.
BMC Medicine|September 15, 2021
The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapySreeram Ramagopalan, Thomas P Leahy, Joshua Ray, et al.
JCO Precision Oncology|December 1, 2023
Exceptional Responses to Selpercatinib in <i>RET</i> Fusion-Driven Metastatic Pancreatic CancerDeepak Bhamidipati, Sireesha Yedururi, Jason Huse, et al.
Pageof 49